Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07578597Enrolling by invitation
Open-label trial (3 arms), sponsored by University Hospital Odense. Primary endpoint: Time spent with interstitial glucose below 3.0 and 3.5 mmol/L and above 7.8 mmol/L. Started Apr 2025; status: enrolling by invitation.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07578597.